TLRY Stock News: Tilray Inc drops as investors await MORE Act vote decision
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADE- NASDAQ:TLRY fell by 2.16% during Wednesday’s trading session.
- Investors await the vote from the House Rules Committee on the MORE Act.
- It was another mixed session for the cannabis industry on Wednesday.
NASDAQ:TLRY saw its trading volatility continue on Wednesday as it extended its streak of alternating between red and green days. Shares of TLRY fell by 2.16% and closed the trading day at $8.14. After the recent bullish uptrend in the markets, all three major indices cooled off on Wednesday, following two straight positive days to open the week. The Dow Jones inched lower by 65 basis points, the S&P 500 fell by 0.63%, and the NASDAQ dropped lower by 1.21% as big tech stocks pulled back from their recent hot stretch.
Stay up to speed with hot stocks' news!
All eyes were on the floor of the House of Representatives on Wednesday, as the House Rules Committee was set to vote on the MORE Act. Unfortunately, the vote was postponed until later in the week. The MORE Act is expected to pass the vote in the House, although just as in 2020, it could meet some opposition in the Senate. The act will finally bring in federal legalization of marijuana in the United States, as well as expunging any accused that are currently serving time for the possession of marijuana products in the past.
TILRAY stock forecast
The cannabis sector experienced more volatility on Wednesday, as stocks like Tilray and Sundial Growers (NASDAQ:SNDL) were trading as much as 9% higher in the morning, before ultimately closing the day below water. Other cannabis stocks like Canopy Growth (NASDAQ:CGC) and Hexo Corp (NASDAQ:HEXO) also fell to close the day, while Aurora Cannabis (NASDAQ:ACB) eked out a small gain for the session.
- NASDAQ:TLRY fell by 2.16% during Wednesday’s trading session.
- Investors await the vote from the House Rules Committee on the MORE Act.
- It was another mixed session for the cannabis industry on Wednesday.
NASDAQ:TLRY saw its trading volatility continue on Wednesday as it extended its streak of alternating between red and green days. Shares of TLRY fell by 2.16% and closed the trading day at $8.14. After the recent bullish uptrend in the markets, all three major indices cooled off on Wednesday, following two straight positive days to open the week. The Dow Jones inched lower by 65 basis points, the S&P 500 fell by 0.63%, and the NASDAQ dropped lower by 1.21% as big tech stocks pulled back from their recent hot stretch.
Stay up to speed with hot stocks' news!
All eyes were on the floor of the House of Representatives on Wednesday, as the House Rules Committee was set to vote on the MORE Act. Unfortunately, the vote was postponed until later in the week. The MORE Act is expected to pass the vote in the House, although just as in 2020, it could meet some opposition in the Senate. The act will finally bring in federal legalization of marijuana in the United States, as well as expunging any accused that are currently serving time for the possession of marijuana products in the past.
TILRAY stock forecast
The cannabis sector experienced more volatility on Wednesday, as stocks like Tilray and Sundial Growers (NASDAQ:SNDL) were trading as much as 9% higher in the morning, before ultimately closing the day below water. Other cannabis stocks like Canopy Growth (NASDAQ:CGC) and Hexo Corp (NASDAQ:HEXO) also fell to close the day, while Aurora Cannabis (NASDAQ:ACB) eked out a small gain for the session.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.